搜尋結果
Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
CNBC· 4 小時前Competition in the blockbuster weight loss drug market is ramping up, as drugmakers share fresh ...
Abbott jumps on RFK Jr. health push — plus, reviews of Eli Lilly's obesity drug data
CNBC· 1 日前Technology and financials were the two big sector winners of the day, with chip stocks surging ...
Novo Nordisk shares fall as obesity pipeline faces investor scrutiny
Reuters· 2 日前... said full results from two late-stage trials of CagriSema - one in people with obesity ... ...
Novo Nordisk Obesity Shot Tied to Greater Weight Loss at Lower Doses
Bloomberg· 3 日前Have a confidential tip for our reporters? Novo Nordisk A/S’s next-generation obesity shot Cagr ...
Nestle USA to phase out use of synthetic food colors by mid-2026
Reuters· 1 小時前, opens new tab said on Wednesday that it would fully eliminate synthetic food colors from its ...
Novo’s Latest Obesity Drug Shows 24% Weight Loss in Small Trial
Bloomberg· 5 日前Have a confidential tip for our reporters? Novo Nordisk A/S’s latest experimental obesity drug ...
Novo Nordisk’s New Obesity Drug Beats Wegovy Weight Loss in Early Trial
The Wall Street Journal· 2 日前Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% ...
Chinese Biotech Showcases Challenger to Eli Lilly’s Obesity Drug
Bloomberg· 4 日前Have a confidential tip for our reporters? An obesity drug from China helped patients lose a ...
The Wegovy effect: A new drug reshapes the lives of teens with obesity
Reuters· 5 日前Reuters delves into the experiences of four American teenagers with obesity who were among the ...
6 stocks to trim after their big runs — plus updates on the rest of our portfolio
CNBC· 3 小時前Jim Cramer and Jeff Marks, the Club's director of portfolio analysis, ran through all 30 ...
obesity 相關
廣告
